Clinical Trial: Efficacy and safety of hepatic arterial infusion chemotherapy combined with apatinib and adebrelimab for high-risk BCLC stage C hepatocellular carcinoma: A single-arm, multicenter, phase II study (China)

China, Sept. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and safety of hepatic arterial infusion chemotherapy combined with apatinib and adebrelimab for high-risk BCLC stage C hepatocellular carcinoma: A single-arm, multicenter, phase II study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131403

Registration Time: 2026/09/01

Type: Interventional study

Primary Sponsor: Sun Yat-Sen University Cancer Center

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=292773

Published by HT Digital Content Services with permission from Health Daily Digest....